by Luke Pettit | Jan 2, 2025 | EPO
Background and First Instance Decisions In Europe, claims directed toward mathematical methods are allowable only if it is clear that they contribute to the “technical character” of an invention. Under European practice, to assess the inventive step of a mathematical...
by David Eyre | Dec 6, 2024 | Uncategorised
Haemophilia B A blot clot is produced following a cascade of reactions after injury. Haemophilia is a disorder of blood clotting whereby one of the factors that contributes to this cascade of reactions is defective. Consequently, for sufferers from this condition...
by Chloe Sullivan | Nov 14, 2024 | UPC
Background The multi-territory dispute between NanoString and 10x Genomics, which has been ongoing in the US and Europe for quite some time, was expanded to the Unified Patent Court soon after it opened its doors in June last year. The battle before the UPC began in...
by David Eyre | Sep 16, 2024 | US & International
Background For valuable inventions it is relatively typical for a US patent to be expanded into a family of patent rights. Naturally, the value of patents is further enhanced by extra patent term. Patents with expiry dates beyond the normal 20 year period can be...
by Sean Hutchinson | Aug 30, 2024 | EPO
Background European patent no. EP 2 991 507 B1 was granted with claims directed to a mixture containing fish oil and fruit juice for use in the treatment of cancer. At opposition, the patent was found to lack novelty and the amendments proposed by the patent...
Recent Comments